Centre Hospitalier De Cholet

Clinical trials at this site focus strongly on oncology, with studies in advanced ovarian cancer, metastatic breast cancer, lung cancer, hepatocellular carcinoma, colon carcinoma, and small bowel adenocarcinoma. The research is aimed at improving treatment effectiveness, extending disease control, and identifying better options for patients with hard-to-treat cancers.

• Testing new cancer treatment combinations for advanced ovarian, breast, and lung cancers
• Evaluating therapies for hepatocellular carcinoma and colorectal cancer after prior treatment
• Studying blood-based tumor markers to help guide personalized cancer care

The site’s cancer research also includes approaches designed to refine treatment selection and support longer progression-free survival for patients with advanced disease.

Research in respiratory tract diseases and intensive care at Centre Hospitalier De Cholet includes trials for ventilator-associated pneumonia and acute respiratory failure. These studies are aimed at improving infection management and supporting safer recovery for critically ill patients.

• Assessing treatments for ventilator-associated pneumonia in the ICU
• Improving care for patients with de novo acute respiratory failure
• Evaluating strategies to help patients come off high-flow nasal oxygen therapy

This area of research reflects a practical focus on better supportive care, faster recovery, and more effective treatment in hospital settings.

Trials in cardiovascular diseases at this hospital address atrial fibrillation and the prevention of stroke or systemic embolism, while other studies examine safer ways to reverse anticoagulation before urgent surgery. The goal is to improve both protection against clot-related events and bleeding safety.

• Comparing treatments to prevent stroke in people with atrial fibrillation
• Studying reversal of anticoagulant effects before urgent procedures
• Balancing thrombotic risk and bleeding risk in clinical care

These studies combine cardiovascular medicine with surgical safety, aiming to support better decisions for patients who need both effective clot prevention and careful bleeding control.

At Centre Hospitalier De Cholet, trials in immune system processes and musculoskeletal diseases include work on polymyalgia rheumatica. The research is focused on reducing relapse, improving symptom control, and helping patients achieve more durable remission.

• Testing new approaches for polymyalgia rheumatica
• Evaluating treatment strategies to maintain sustained remission
• Studying ways to improve outcomes in inflammatory rheumatic disease

This area highlights the site’s interest in autoimmune and inflammatory conditions, with an emphasis on better long-term disease management.

Clinical research in digestive system diseases includes studies of colon carcinoma, small bowel adenocarcinoma, and hepatocellular carcinoma. These trials are evaluating new treatment combinations and ways to improve outcomes for patients with advanced gastrointestinal cancers.

• Exploring treatment options for small bowel adenocarcinoma
• Assessing therapies for hepatocellular carcinoma
• Supporting better disease control in colorectal cancer

The research portfolio reflects ongoing efforts to strengthen cancer care across several digestive and liver-related malignancies.